UroGen Pharma Ltd. (URGN) › Total AssetsUroGen Pharma Ltd. (URGN) — Total AssetsAnnual figures by fiscal year, from SEC filings.2016: $23.06M2017: $75.55M2018: $103.56M2019: $202.39M2020: $122.00M2021: $119.75M2022: $135.62M2023: $178.31M2024: $285.71M2025: $200.46M$200.46M2016Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$200.46M-29.8%2024$285.71M+60.2%2023$178.31M+31.5%2022$135.62M+13.3%2021$119.75M-1.9%2020$122.00M-39.7%2019$202.39M+95.4%2018$103.56M+37.1%2017$75.55M+227.7%2016$23.06M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share